TICAM-1 Antibodies

Santa Cruz Biotechnology features a diverse variety of TICAM-1 monoclonal antibodies for research focused on understanding TICAM-1's role in immune response. TICAM-1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).TICAM-1, also known as TRIF, is a crucial adaptor protein involved in the signaling pathways of Toll-like receptors (TLRs), particularly TLR3 and TLR4. TICAM-1 plays a significant role in the innate immune response by mediating the production of pro-inflammatory cytokines and type I interferons, which are essential for antiviral defense. Understanding TICAM-1 function is vital for elucidating mechanisms of immune regulation and potential therapeutic targets in various diseases. TICAM-1 research has revealed important insights into cellular signaling mechanisms and inflammatory responses. Investigating TICAM-1 pathways can lead to better understanding of autoimmune disorders and viral infections. Recent studies have highlighted TICAM-1's importance in vaccine development and immunotherapy strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of immune system regulation and disease treatment approaches.